PharmaTher Holdings Ltd

NEW
XCNQ:PHRM (Canada)  
C$ 0.22 (-2.27%) Oct 31
At Loss
P/B:
7.16
Market Cap:
C$ 19.47M ($ 13.99M)
Enterprise V:
C$ 16.88M ($ 12.12M)
Volume:
352.44K
Avg Vol (2M):
107.24K
Trade In:
Volume:
352.44K
At Loss
Avg Vol (2M):
107.24K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for PharmaTher Holdings Ltd ( ) from 2021 to Oct 31 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. PharmaTher stock (XCNQ:PHRM) PE ratio as of Oct 31 2024 is 0. More Details

PharmaTher Holdings Ltd (XCNQ:PHRM) PE Ratio (TTM) Chart

To

PharmaTher Holdings Ltd (XCNQ:PHRM) PE Ratio (TTM) Historical Data

Total 870
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
PharmaTher PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-11-01 At Loss 2024-08-28 At Loss
2024-10-31 At Loss 2024-08-27 At Loss
2024-10-30 At Loss 2024-08-26 At Loss
2024-10-29 At Loss 2024-08-23 At Loss
2024-10-28 At Loss 2024-08-22 At Loss
2024-10-25 At Loss 2024-08-21 At Loss
2024-10-24 At Loss 2024-08-20 At Loss
2024-10-23 At Loss 2024-08-19 At Loss
2024-10-22 At Loss 2024-08-16 At Loss
2024-10-21 At Loss 2024-08-15 At Loss
2024-10-18 At Loss 2024-08-14 At Loss
2024-10-17 At Loss 2024-08-13 At Loss
2024-10-16 At Loss 2024-08-12 At Loss
2024-10-15 At Loss 2024-08-09 At Loss
2024-10-11 At Loss 2024-08-08 At Loss
2024-10-10 At Loss 2024-08-07 At Loss
2024-10-09 At Loss 2024-08-06 At Loss
2024-10-08 At Loss 2024-08-02 At Loss
2024-10-07 At Loss 2024-08-01 At Loss
2024-10-04 At Loss 2024-07-31 At Loss
2024-10-03 At Loss 2024-07-30 At Loss
2024-10-02 At Loss 2024-07-29 At Loss
2024-10-01 At Loss 2024-07-26 At Loss
2024-09-30 At Loss 2024-07-25 At Loss
2024-09-27 At Loss 2024-07-24 At Loss
2024-09-26 At Loss 2024-07-23 At Loss
2024-09-25 At Loss 2024-07-22 At Loss
2024-09-24 At Loss 2024-07-19 At Loss
2024-09-23 At Loss 2024-07-18 At Loss
2024-09-20 At Loss 2024-07-17 At Loss
2024-09-19 At Loss 2024-07-16 At Loss
2024-09-18 At Loss 2024-07-15 At Loss
2024-09-17 At Loss 2024-07-12 At Loss
2024-09-16 At Loss 2024-07-11 At Loss
2024-09-13 At Loss 2024-07-10 At Loss
2024-09-12 At Loss 2024-07-09 At Loss
2024-09-11 At Loss 2024-07-08 At Loss
2024-09-10 At Loss 2024-07-05 At Loss
2024-09-09 At Loss 2024-07-04 At Loss
2024-09-06 At Loss 2024-07-03 At Loss
2024-09-05 At Loss 2024-07-02 At Loss
2024-09-04 At Loss 2024-06-28 At Loss
2024-09-03 At Loss 2024-06-27 At Loss
2024-08-30 At Loss 2024-06-26 At Loss
2024-08-29 At Loss 2024-06-25 At Loss

PharmaTher Holdings Ltd (XCNQ:PHRM) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.